Analyses of a Novel Signaling Molecule, Cas
Analyses of a Novel Signaling Molecule, Cas
批准号:
09044271
负责人:
HIRAI Hisamaru
金额:
$5.44万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for international Scientific Research
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
p13 OCas是一种衔接蛋白,其具有SH 3结构域,随后在底物结构域中具有多个SH 2结合基序。它还含有一个酪氨酸残基和一个富含脯氨酸的序列的C端附近,这是结合位点的SH 2和SH 3结构域的Src激酶,分别。Cas在整合素刺激后被诱导酪氨酸磷酸化。我们研究了气体的亚细胞定位,并确定其本地化所需的区域,以局灶性粘连。在非转化细胞中,Cas主要定位于细胞质,部分定位于粘着斑。然而,在527 F-c-Src转化的细胞中,Gas主要定位于podosomes。在表达激酶阴性527 F/295 M-c-Src的细胞中观察到Cas定位于粘着斑。Cas的SH 3结构域对于其在非转化细胞中定位于粘着斑是必需的,而Cas的SH 3结构域和C末端Src结合结构域两者在527 F-c-Src-Cas中都是必需的。 ...更多信息 RMED细胞和纤连蛋白刺激的细胞。此外,在Src阴性细胞中,Gas局部粘连被消除。这些结果表明Cas的SH 3结构域和Cas与Src激酶的结合在Gas定位于粘着斑中起关键作用。为了确定其在体内的作用,我们产生了缺乏Gas的小鼠。缺乏气体的胚胎在子宫内死亡,表现出明显的全身充血和生长迟缓。组织学上,心脏发育不良,血管明显扩张。心脏的电子显微镜分析显示肌原纤维的解体和Z盘的破坏。此外,肌动蛋白应力纤维的形成严重受损的Cas缺陷的原代成纤维细胞。此外,表达激活的Src在Cas缺陷的原代成纤维细胞没有诱导一个完全转化的表型,可能是由于不足的积累肌动蛋白细胞骨架的podosomes。这些发现已经定义了Gas在心血管发育、肌动蛋白丝组装和Src诱导的转化中的功能。少
英文摘要
p13OCas is an adapter protein that has an SH3 domain followed by multiple SH2 binding motifs in the substrate domain. It also contains a tyrosine residue and a proline-rich sequence near the C terminus, which are the binding sites for the SH2 and SH3 domains of Src kinase, respectively. Cas was shown to be inducibly tyrosine phosphorylated upon integrin stimulation. We examined the subcellular localization of Gas and determined the regions required for its localization to focal adhesions. In nontransformed cells, Cas was localized predominantly to the cytoplasm and partially to focal adhesions. However, in 527F-c-Src-transformed cells, Gas was localized mainly to podosomes. The localization of Cas to focal adhesions was observed in cells expressing the kinase-negative 527F/295M-c-Src. The SH3 domain of Cas is necessary for its localization to focal adhesions in nontransformed cells while both the SH3 domain and the C-terminal Src binding domain of Cas are required in 527F-c-Src-transfo … More rmed cells and fibronectin-stimulated cells. In addition, the localization of Gas to focal adhesions was abolished in Src-negative cells. These results demonstrate that the SH3 domain of Cas and the association of Cas with Src kinase play a pivotal role in the localization of Gas to focal adhesions. To determine its role in vivo, we generated mice lacking Gas. Gas-deficient embryos died in utero showing marked systemic congestion and growth retardation. Histologically, the heart was poorly developed and blood vessels were prominently dilated. Electron microscopic analysis of the heart revealed disorganization of myofibrils and disruption of Z-disks. In addition, actin stress fiber formation was severely impaired in Cas-deficient primary fibroblasts. Moreover, expression of activated Src in Cas-deficient primary fibroblasts did not induce a fully transformed phenotype, possibly owing to insufficient accumulation of actin cytoskeleton in podosomes. These findings have defined Gas function in cardiovascular development, actin filament assembly and Src-induced transformation. Less
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Sakai R: "Characterization of the kinase activity essential for tyrosine phosphorylation of p130Cas in mouse fibroblasts." Oncogene. 14. 1419-1426 (1997)
Sakai R:“小鼠成纤维细胞中 p130Cas 酪氨酸磷酸化所必需的激酶活性的表征。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Astier A: "The related adhesion focal tyrosine kinase differentially phosphorylates p130Cas and the Cas-like protein, p105HEF1." J.Biol.Chem.272. 4230-4236 (1997)
Astier A:“相关的粘附局灶酪氨酸激酶对 p130Cas 和 Cas 样蛋白 p105HEF1 进行差异磷酸化。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kanda H: "Ligation of the T cell antigen receptor induces tyrosine phosphorylation of p105CasL, a member of the p130Cas-related docking protein family, and its subsequent binding to the Src homology 2 domain of c-Crk." Eur.J.Immunol.27. 2113-2117 (1997)
Kanda H:“T 细胞抗原受体的连接诱导 p105CasL(p130Cas 相关对接蛋白家族的成员)的酪氨酸磷酸化,以及随后与 c-Crk 的 Src 同源 2 结构域的结合。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Honda H,Oda H,Nakamoto T,Honda Z,Sakai R,Suzuki T,Saito T,Nakamura K,Nakao K,Ishikawa T,Katsuki M,Yazaki Y,Hirai H.: "Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas." Nature Genet. 19.
Honda H、Oda H、Nakamoto T、Honda Z、Sakai R、Suzuki T、Saito T、Nakamura K、Nakao K、Ishikawa T、Katsuki M、Yazaki Y、Hirai H.:“心血管异常、肌动蛋白成束受损和抵抗力
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nakamoto T: "Requirements for the localization of p130Cas to Focal Adhesions." Mol.Cell.Biol.17. 3884-3897 (1997)
Nakamoto T:“p130Cas 局部粘连的定位要求。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 17 条
Analyses of Maltipotential Functions of a Novel Signaling Molecule, Cas
-
批准号:11694250
-
项目类别:Grant-in-Aid for Scientific Research (A).
-
资助金额:$5.57万
-
财政年份:1999
-
负责人:HIRAI Hisamaru
-
依托单位:
Practical development of a novel method for hematopoietic stem cell expansion
-
批准号:09357010
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$18.24万
-
财政年份:1997
-
负责人:HIRAI Hisamaru
-
依托单位:
Analysis of molecular mechanisms of leukemia development
-
批准号:09307021
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$24.58万
-
财政年份:1997
-
负责人:HIRAI Hisamaru
-
依托单位:
Analysis of Molecular Mechanism of Blastic Crisis in Chronic Myelocytic Leukemia
-
批准号:07042002
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$3.65万
-
财政年份:1995
-
负责人:HIRAI Hisamaru
-
依托单位:
Functional analysis of AML1 gene in normal hematopoietic cells and leukemia cells
-
批准号:07457229
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.48万
-
财政年份:1995
-
负责人:HIRAI Hisamaru
-
依托单位:
Molecular analysis of leukemias with chromosomal translocation and its application for clinical Diagnosis
-
批准号:05454328
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.1万
-
财政年份:1993
-
负责人:HIRAI Hisamaru
-
依托单位:
Molecular Diagnosis of Human Leukemias
-
批准号:04253208
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$12.16万
-
财政年份:1992
-
负责人:HIRAI Hisamaru
-
依托单位:
Development and clinical application of molecular diagnosis in leukemias
-
批准号:04557133
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$9.73万
-
财政年份:1992
-
负责人:HIRAI Hisamaru
-
依托单位:
Analysis of signal transduction mechanism through a novel tyrosine kinase receptor
-
批准号:03454521
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.9万
-
财政年份:1991
-
负责人:HIRAI Hisamaru
-
依托单位:
国内基金
海外基金
登录
查看更多内容
桑黄新菌株 SH3 抗肝癌活性代谢产物的鉴定及功能分析
-
批准号:2022JJ40233
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:唐少军
-
依托单位:
LIM和SH3蛋白1通过介导糖代谢重组诱导胃癌曲妥珠单抗耐药的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:史蛟龙
-
依托单位:
SH3结构域蛋白Dlish调控果蝇Hippo信号通路的分子机制研究
-
批准号:31801190
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2018
-
负责人:王兴
-
依托单位:
c-Src的SH3结构域作为低出血风险的抗血栓新靶点的研究
-
批准号:81670127
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2016
-
负责人:奚晓东
-
依托单位:
具有双区识别功能的Src酪氨酸激酶SH3结构域配体的设计合成与生物功能的研究
-
批准号:21002013
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:古险峰
-
依托单位:
Src的结构域SH3调控细胞骨架蛋白功能在肺腺癌侵袭转移中的分子机制研究
-
批准号:81001045
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2010
-
负责人:何萍
-
依托单位:
人的SH3结合结构域激酶-1(SBK1)功能和分子机制研究
-
批准号:30600549
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2006
-
负责人:王平章
-
依托单位:
核磁共振法研究亨廷顿蛋白中脯氨酸丰富区域与SH3和双WW结构域的相互作用
-
批准号:30670431
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2006
-
负责人:胡红雨
-
依托单位:
肝癌高表达新基因HCC A1的磷酸化及SH3结合结构域功能研究
-
批准号:30070833
-
项目类别:面上项目
-
资助金额:18.0万元
-
批准年份:2000
-
负责人:曾锦章
-
依托单位: